Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de36eaaa471d491a1c3f2ae25eaef97 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-853 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate |
2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b72fbbc8682ac2f988042aa7879e1839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a139cf3f71a5aa1468fa7c67c5ad6d |
publicationDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-527493-A |
titleOfInvention |
Endotoxin binding by lactobacillus and bifidobacteria having hydrophobic surface properties and use of the bacteria in treating endotoxin ( LPS ) mediated disorders |
abstract |
Described are isolated strains of lactic acid bacteria or bifidobacteria having hydrophobic surface properties wherein the percent hydrophobicity is at least 80% and the ability to bind endotoxins, provided the bifidobacteria is Bifidobacterium bifidum NCC189 (CNCM-I-2333) or Bifidobacterium bifidum NCC 235 (CNCM-I-2335). The bacteria can be used in human or pet food compositions associated with an ingestible support or a pharmaceutical matrix and are useful preventing or treating endotoxin mediated disorders. Preferred strains are Lactobacillus acidophilus NCC 2463 (CNCM-I 2623), Bifidobacterium bifidum NCC 251 (CNCM-I-2168) and Bifidobacterium lactis (ATCC 27536). |
priorityDate |
2001-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |